| Zacks Company Profile for China Medicine Corp. (CHME : OTC) |
|
|
| |
| Company Description |
| China Medicine Corporation is a distributor of pharmaceutical and medical products, including prescription and over-the-counter drugs, Chinese herbs, traditional Chinese medicines made from Chinese herbs, nutritional supplements, dietary supplements, and medical instruments. The company is also engaged in proprietary research and development with the aim of creating new pharmaceutical products and intellectual property that it may sell in the future. China Medicine Corporation also sells improved drug formulas after purchasing the rights to drug formulas at an early stage of development and improving those formulas through its own research. The company's mission is to become a leading research-driven pharmaceutical company in China dedicated to the discovery, development, distribution and manufacturing of pharmaceutical products and nutritional supplements.
Number of Employees: |
|
|
| |
| Price / Volume Information |
| Yesterday's Closing Price: $0.04 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 31,460 shares |
| Shares Outstanding: (millions) |
| Market Capitalization: $ (millions) |
| Beta: 228.83 |
| 52 Week High: $0.04 |
| 52 Week Low: $0.00 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
3,233.33% |
3,146.00% |
| 12 Week |
6,566.67% |
6,290.24% |
| Year To Date |
1,233.33% |
1,065.46% |
|
|
|
|
| |
| Address & Contact Information |
| Street Address |
Phone / Fax |
Email Address |
Web URL |
GUANGRI TOWER SUITE 702 - GUANGZHOU,F4 510600 CHN |
ph: 86-20-8739-1718 fax: - |
ir@cmc621.com |
http://www.cmc621.com |
|
|
| |
| General Corporate Information |
Officers
- - -
- - -
- - -
- - -
- - -
|
|
Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-GENERIC DRG
Sector: Medical
CUSIP: 169491107
SIC: 5122
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: -
Next Expected EPS Date: -
|
|
Share - Related Items
Shares Outstanding:
Most Recent Split Date: 2.00 (2.00:1)
Beta: 228.83
Market Capitalization: $ (millions)
|
|
|
|
|
| |
| EPS Information |
Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.00% |
| Current Fiscal Quarter EPS Consensus Estimate: $ |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $ |
Payout Ratio: |
| Number of Estimates in the Fiscal Year Consensus: |
Change In Payout Ratio: |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: - |
|
|
|
| |